DSOB adds staffer
Executive Summary
Mary Mease joins FDA's Drug Safety Oversight Board as a science policy analyst, the agency announced Nov. 4. Mease previously worked in the Center for Drug Evaluation & Research's Division of Scientific Investigators; she has also worked as a safety evaluator in the Office of Drug Safety's Division of Drug Risk Evaluation. Mease's appointment is expected to complete the board's staff (1"The Pink Sheet" Oct. 24, 2005, p. 5)...
You may also be interested in...
FDA’s Drug Safety Oversight Board Adds Staff To Manage Operations
FDA is adding three new staffers dedicated to working full time on the operations and communications of the Drug Safety Oversight Board
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.